SHPH Stock Price & Analysis — Shuttle Pharmaceuticals Inc (Healthcare >> Drug Manufacturers - Specialty & Generic)
SHPH FAQ
What is SHPH's ROE?
Shuttle Pharmaceuticals Inc reports a Return on Equity (ROE) of -323.38%.
What is SHPH's dividend yield?
Shuttle Pharmaceuticals Inc offers a dividend yield of 0.00%.
What is SHPH's Quality Score?
Our AI rates SHPH's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SHPH?
Our AI Timing Score for SHPH is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SHPH belong to?
Shuttle Pharmaceuticals Inc is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange
SHPH AI Analysis Summary
Our AI summary for SHPH: Shuttle Pharmaceuticals Inc (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.00, ROE of -323.38%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 3.80
Price
0.71
(22.98%)
Day Change
|
|
|---|
SHPH, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 3.80 |
| PBV / Sector |
0.54 / 3.22
GREAT
|
| Earning Per Share | -22.74 |
| PE / Sector |
N/A / 29.79
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
16.08 M
GREAT
|
| Average 1W Daily Value |
2.68 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:28 |
| Symbol | SHPH |
| Name | SHUTTLE PHARMACEUTICALS INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 0.59 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1.81 / 10,754.62 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 401 Professional Drive, Gaithersburg, MD, United States, 20879
Phone: 240 403 4212
Website: https://www.shuttlepharma.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Top Related Stocks
Stocks in the Same Sector
Healthcare › Drug Manufacturers - Specialty & GenericAnalysed on the same criteria, ordered by market cap
Google